167 filings
Page 5 of 9
8-K
7ggnpbkopu1w4f0x v6
10 Jan 19
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
5:04pm
8-K
90xw4 xbey
9 Jan 19
Cancer Genetics Strengthens Management Team with Appointmentof William Finger as Executive Vice President, Precision Medicineand Pharma Services
9:12am
8-K
6o95ni
7 Jan 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
77w0q
21 Dec 18
Other Events
4:05pm
8-K
osvkjnfh8vj
17 Dec 18
Cancer Genetics Terminates Proposed Merger with NovellusDx
8:31am
8-K/A
i2sj37sw7
21 Nov 18
Departure of Directors or Certain Officers
4:10pm
8-K
9dqc0xj gmf305xsk
19 Nov 18
Provides Strategic Business Updates
4:56pm
8-K
iip23c
16 Nov 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
f5ptrxq
14 Nov 18
Cancer Genetics Appoints Glenn Miles as Chief Financial Officer
4:44pm
8-K
zmcop35u
16 Oct 18
Cancer Genetics Issues Letter to Shareholders
4:05pm
8-K
tytucnzrk0uyocx
9 Oct 18
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
8:47am
8-K
8h4b2
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
uiwcfwzwlvxid6wq
21 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
87em4 4sewksav6uv5m2
14 Aug 18
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
7:35am
8-K
mcs4o8
13 Aug 18
Departure of Directors or Certain Officers
4:05pm
8-K
6r4 kbv8lsisa
9 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
d9y7n67167jntktu f60
18 Jul 18
Cancer Genetics Closes $2.625 million Convertible Note Financing
4:18pm
8-K
fy8xr8nmixd pl
5 Jul 18
Entry into a Material Definitive Agreement
4:59pm
8-K
6yy9co6 qaykzson3p6
27 Jun 18
Entry into a Material Definitive Agreement
4:05pm
8-K
yi89ku
13 Jun 18
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
12:00am